Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension - 03/09/11
Doi : 10.1016/S0002-9149(00)01512-5
Funmi M. Belgore, PhD a, Andrew D. Blann, PhD a, F.L. Li-Saw-Hee a : MRCP, D.Gareth Beevers, MD a, Gregory Y.H. Lip, MD a, ⁎ 
a Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom
*Dr. Lip’s address is: Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, United Kingdom
| ☆ | This study was supported in part by City Hospital NHS Trust Research and Development Program for the Haemostasis Thrombosis and Vascular Biology Unit. Dr. Li-Saw-Hee was supported by an educational nonpromotional research fellowship from Merck Sharpe & Dohme, United Kingdom. |
© 2001
Excerpta Medica Inc. Tous droits réservés.
Vol 87 - N° 6
P. 805-807 - mars 2001 Retour au numéro
Article précédent
- Electrophysiologic effects and efficacy of intravenous propafenone in terminating atrioventricular reentrant tachycardia in children
- Gabriele Hessling, Konrad Brockmeier, Heinz-Juergen Ruediger, Herbert E. Ulmer
- Rate of progression of valvular aortic stenosis in patients ?60 years of age
- Doron Nassimiha, Wilbert S. Aronow, Chul Ahn, Martin E. Goldman
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?